Cargando…
Chinese health biotech and the billion-patient market
Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096943/ https://www.ncbi.nlm.nih.gov/pubmed/18183014 http://dx.doi.org/10.1038/nbt0108-37 |
_version_ | 1783510930414370816 |
---|---|
author | Frew, Sarah E Sammut, Stephen M Shore, Alysha F Ramjist, Joshua K Al-Bader, Sara Rezaie, Rahim Daar, Abdallah S Singer, Peter A |
author_facet | Frew, Sarah E Sammut, Stephen M Shore, Alysha F Ramjist, Joshua K Al-Bader, Sara Rezaie, Rahim Daar, Abdallah S Singer, Peter A |
author_sort | Frew, Sarah E |
collection | PubMed |
description | Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7096943 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-70969432020-03-26 Chinese health biotech and the billion-patient market Frew, Sarah E Sammut, Stephen M Shore, Alysha F Ramjist, Joshua K Al-Bader, Sara Rezaie, Rahim Daar, Abdallah S Singer, Peter A Nat Biotechnol Article Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users. Nature Publishing Group US 2008 /pmc/articles/PMC7096943/ /pubmed/18183014 http://dx.doi.org/10.1038/nbt0108-37 Text en © Nature Publishing Group 2008 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Frew, Sarah E Sammut, Stephen M Shore, Alysha F Ramjist, Joshua K Al-Bader, Sara Rezaie, Rahim Daar, Abdallah S Singer, Peter A Chinese health biotech and the billion-patient market |
title | Chinese health biotech and the billion-patient market |
title_full | Chinese health biotech and the billion-patient market |
title_fullStr | Chinese health biotech and the billion-patient market |
title_full_unstemmed | Chinese health biotech and the billion-patient market |
title_short | Chinese health biotech and the billion-patient market |
title_sort | chinese health biotech and the billion-patient market |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096943/ https://www.ncbi.nlm.nih.gov/pubmed/18183014 http://dx.doi.org/10.1038/nbt0108-37 |
work_keys_str_mv | AT frewsarahe chinesehealthbiotechandthebillionpatientmarket AT sammutstephenm chinesehealthbiotechandthebillionpatientmarket AT shorealyshaf chinesehealthbiotechandthebillionpatientmarket AT ramjistjoshuak chinesehealthbiotechandthebillionpatientmarket AT albadersara chinesehealthbiotechandthebillionpatientmarket AT rezaierahim chinesehealthbiotechandthebillionpatientmarket AT daarabdallahs chinesehealthbiotechandthebillionpatientmarket AT singerpetera chinesehealthbiotechandthebillionpatientmarket |